Osteoporosis Protocol

MusculoskeletalStrong Evidence

supplements

Primary

Supporting

Grade A

105

Studies

Primary Stack

Core supplements with strongest evidence

Vitamin D3A

2000-4000 IU daily (target 40-60 ng/mL)

Essential for calcium absorption; deficiency causes secondary hyperparathyroidism and bone loss

↑Bone Mineral Density↑Fracture Risk↑Bone-specific Alkaline Phosphatase

40 studies15,000 participants

Supporting Studies (1)

PMID: 29279934 - Vitamin D and fracture prevention meta-analysis (2018)

CalciumA

1000-1200mg daily (from diet + supplements, divided doses)

Primary mineral component of bone matrix; adequate intake reduces bone resorption

30 studies12,000 participants

Vitamin K2 (MK-7)B

100-200mcg daily

Activates osteocalcin for calcium deposition in bone; prevents arterial calcification

↑Bone Mineral Density↑Fracture Risk↑Estrogen↓Total cholesterol↓Weight

12 studies1,800 participants

Supporting Studies (1)

PMID: 23525894 - Vitamin K2 and bone health (2013)

Supporting Stack

Additional supplements for enhanced results

MagnesiumB

400-500mg daily

50-60% of body magnesium is in bone; needed for vitamin D activation and PTH function

8 studies520 participants

Collagen PeptidesB

10-15g daily

Provides amino acids for bone matrix; may stimulate osteoblast activity

6 studies380 participants

Strontium (low dose)B

680mg strontium citrate daily (separate from calcium)

Incorporates into bone matrix; may stimulate osteoblasts and inhibit osteoclasts

5 studies450 participants

BoronC

3-6mg daily

Reduces urinary calcium and magnesium loss; supports vitamin D metabolism

4 studies180 participants

How This Protocol Works

Simple Explanation

Osteoporosis occurs when bone breakdown exceeds bone formation, leading to fragile bones and fracture risk. This protocol provides the essential nutrients for maintaining and rebuilding bone.

•Vitamin D is absolutely essential—without adequate vitamin D, you only absorb 10-15% of dietary calcium instead of 30-40%. Most people with osteoporosis are deficient. Target blood level: 40-60 ng/mL.

•Calcium provides the raw material for bone. The key is getting 1000-1200mg total daily from diet plus supplements, taken in divided doses (no more than 500mg at once for best absorption).

•Vitamin K2 (MK-7) directs calcium into bones and teeth rather than arteries. It activates osteocalcin, the protein that binds calcium to bone matrix. K2 also prevents the vascular calcification that can occur with calcium supplementation.

•Magnesium is often overlooked—over half of your body's magnesium is in bone. It's needed to convert vitamin D to its active form and for proper parathyroid function.

•Collagen peptides provide the protein scaffold that minerals attach to. Studies show improved bone density with daily collagen.

•Strontium can substitute for calcium in bone, potentially improving density. Use nutritional doses, not pharmaceutical ranelate.

•Boron helps retain calcium and works with vitamin D.

Critical: Weight-bearing exercise is essential. These supplements support but don't replace bisphosphonates if indicated.

Expected timeline: Bone density changes take 1-2 years to measure. Focus on consistent, long-term intake.

Clinical Perspective

Osteoporosis reflects imbalanced bone remodeling favoring osteoclast resorption over osteoblast formation. T-score ≤-2.5 defines osteoporosis; fracture risk doubles per SD decrease in BMD.

•Vitamin D3 (A-grade): 25-OH-D levels <30 ng/mL cause secondary hyperparathyroidism, accelerating bone loss. Meta-analysis (PMID: 29279934): D + calcium reduces hip fractures ~30% vs placebo. Target 40-60 ng/mL for optimal bone health.

•Calcium (A-grade): 1000-1200mg daily total intake (diet + supplements). Split doses for absorption (≤500mg per dose). Citrate preferred over carbonate for achlorhydric patients. Recent cardiovascular concerns may be mitigated by K2.

•Vitamin K2 MK-7 (B-grade): γ-carboxylates osteocalcin (bone formation) and matrix Gla protein (prevents vascular calcification). Japanese trials (PMID: 23525894) show vertebral fracture reduction. MK-7 has longer half-life than MK-4.

•Magnesium (B-grade): 50-60% of body Mg in bone. Required for 1α-hydroxylase (vitamin D activation), PTH secretion. Deficiency causes low-grade inflammation and impaired osteoblast function.

•Collagen peptides (B-grade): Provides glycine, proline, hydroxyproline for bone matrix synthesis. May stimulate osteoblasts via specific collagen peptides. RCTs show improved BMD at 5-10g daily.

•Strontium (B-grade): Incorporates into hydroxyapatite. Stimulates osteoblasts via CaSR, inhibits osteoclasts. Nutritional strontium citrate (not ranelate) at 680mg shows BMD improvement. Take apart from calcium (2-hour separation).

•Boron (C-grade): Reduces urinary Ca/Mg excretion, extends vitamin D half-life. Epidemiological link to arthritis prevention.

Monitoring: DXA (baseline, q2 years), 25-OH-D level, bone turnover markers (CTX, P1NP), calcium, PTH.

Medication consideration: For high fracture risk (FRAX >20% major, >3% hip), pharmacotherapy (bisphosphonates, denosumab) indicated alongside nutritional support.

View All Protocols